Qigong for Post Acute Sequelae of COVID-19 Infection

Long COVID Clinical Trial

Official title:

Qigong for Post Acute Sequelae of COVID-19 Infection

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05675995
• Other study ID #: 1846783
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 4, 2023
• Est. completion date: July 30, 2024

Study information

• Verified date: April 2024
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to conduct a pilot feasibility study of external qigong on health-related quality of life in individuals with prolonged symptoms following COVID-19 infection.

Description:

The purpose of this study is to determine whether external qigong, a traditional Chinese medicine healing practice, improves quality of life and symptoms for individuals with prolonged symptoms following a COVID-19 infection (sometimes called "long COVID"). The study involves completing questionnaires and participating in 6 weekly in person small group qigong sessions with an experienced qigong practitioner.

Participants will be randomized to participate in either an immediate or waitlist control group that will receive the qigong sessions starting 8 weeks later. Participants will complete 3 sets of questionnaires, each about 8 weeks apart and an interview about their experiences with qigong after completing the 6 sessions.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 40
• Est. completion date: July 30, 2024
• Est. primary completion date: May 13, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. English-speaking adults age 18 or greater

2. History of a COVID-19 infection with lingering symptoms lasting longer than 12 weeks

3. Willing and able to access the internet to complete questionnaires

4. Willing and able to travel to the qigong sessions to participate in person in Sacramento, CA.

Exclusion Criteria:

1. Lung scarring secondary to COVID-19 infection as evidenced by signs of parenchymal lung damage on imaging or FVC < 80% (any patient with post COVID-related shortness of breath must have PFTs to be considered for enrollment).

2. Dementia

3. Any other condition that makes it difficult for the individual to complete questionnaires or attend the qigong sessions.

Related Conditions & MeSH terms

• Long COVID

Intervention

Behavioral:
• External Qigong
6 sessions of external qigong delivered in a group-based format once a week.

Locations

Country	Name	City	State
United States	University of California Davis Health	Sacramento	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in physical health	Change in PROMIS-29 physical health summary score from before to after intervention in all participants	8 weeks